Effects of verapamil and elgodipine on isoprenaline-induced metabolic responses in rabbits

被引:8
作者
García-Barrado, MJ [1 ]
Sancho, C [1 ]
Iglesias-Osma, MC [1 ]
Moratinos, J [1 ]
机构
[1] Univ Salamanca, Fac Med, Dept Fisiol & Farmacol, Salamanca 37007, Spain
关键词
Ca2+ channel antagonist; glucose homeostasis; insulin secretion; isoprenaline; lipolysis; (rabbit);
D O I
10.1016/S0014-2999(01)00808-1
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Verapamil (0.17 mug kg(-1) min(-1) intravenous, i.v.) but not elgodipine (35 ng kg(-1) min(-1)) modestly enhanced the weak blood glucose increase induced by the i.v. infusion of isoprenaline (0.3 mug kg(-1) min(-1)) in conscious rabbits. However, elgodipine but nor verapamil suppressed the increase in circulating insulin evoked by the agonist. Both drugs enhanced the rise in plasma lactate mediated by isoprenaline but only elgodipine potentiated the lipolytic effect of the agonist. in isolated islets elgodipine (10(-6) M) blocked forskolin (10(-6) M)-induced insulin release. However, in rabbit adipocytes elgodipine potentiated both glycerol release and cAMP accumulation induced by isoprenaline (10(-8)-10(-6) M). Excess K+ (40-60 mM) did not alter basal lipolysis or the response to isoprenaline in either rabbit or mouse adipocytes. Therefore, Ca2+ influx through L-type Ca2+ channels does not seem to play a significant role in the lipolytic effect of isoprenaline. Metabolic alterations found with Ca2+ channel antagonists were of minor intensity and probably devoid of pathological implications. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 54 条
[1]
Calcium-antagonist drugs [J].
Abernethy, DR ;
Schwartz, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (19) :1447-1457
[2]
A specific beta(3)-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats [J].
Atef, N ;
Lafontan, M ;
Double, A ;
Helary, C ;
Ktorza, A ;
Penicaud, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (03) :287-292
[3]
What have we learned from the calcium channel blocker controversy? [J].
Califf, RM ;
Kramer, JM .
CIRCULATION, 1998, 97 (16) :1529-1531
[4]
ANTILIPOLYTIC EFFECTS OF ALPHA(2)-ADRENERGIC AGONISTS, NEUROPEPTIDE-Y, ADENOSINE, AND PGE(1) IN MAMMAL ADIPOCYTES [J].
CASTAN, I ;
VALET, P ;
QUIDEAU, N ;
VOISIN, T ;
AMBID, L ;
LABURTHE, M ;
LAFONTAN, M ;
CARPENE, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :R1141-R1147
[5]
VASCULAR AND ENDOCRINE CONTROL OF MUSCLE METABOLISM [J].
CLARK, MG ;
COLQUHOUN, EQ ;
RATTIGAN, S ;
DORA, KA ;
ELDERSHAW, TPD ;
HALL, JL ;
YE, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E797-E812
[6]
Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide [J].
Ding, WG ;
Gromada, J .
DIABETES, 1997, 46 (04) :615-621
[7]
DOLE VP, 1960, J BIOL CHEM, V235, P2595
[8]
ROLE OF CALCIUM AND CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE IN ANTILIPOLYTIC EFFECT OF TOLBUTAMIDE AND GLIBENCLAMIDE [J].
EBERT, R ;
HILLEBRAND, O ;
SCHWABE, U .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :181-194
[9]
REQUIREMENT FOR BIVALENT-CATIONS IN THE ACTIONS OF INSULIN AND SODIUM-NITROPRUSSIDE ON METABOLISM IN RAT ADIPOCYTES [J].
EMAMI, S ;
PERRY, MC .
FEBS LETTERS, 1986, 200 (01) :51-57
[10]
Faintrenie G, 1998, J PHARMACOL EXP THER, V286, P607